Cagrilintide, AM-833, NN-0174-0833/white powder, acylated amylin analogue

Product Description
This product is Cagrilintide (former code name AM-833 / NN-0174-0833) with CAS No. 1415456-99-3. It is a structurally optimized long-acting polypeptide compound, an analogue of the natural human hormone Amylin, and is produced via peptide synthesis technology. Its molecular formula is approximately C₁₉₄H₃₁₂N₅₄O₅₉S₂ with a molecular weight of around 4409.0. It normally appears as a white lyophilized powder, and its research-grade purity can reach over 99% (tested by HPLC). As an innovative drug peptide raw material, this product is mainly provided for research institutions, pharmaceutical enterprises and related research purposes. It generally requires sealed storage under low temperature (-20℃).

Product Functions
Cagrilintide acts on the human appetite regulation system. As a long-acting amylin analogue, it targets the satiety center in the central nervous system, helping prolong satiety and suppress excessive eating desire, thus exerting effects on energy intake and weight management. Compared with similar weight-loss drugs, it features a long duration of action and flexible dosing intervals. In clinical studies, when combined with GLP-1 weight-loss drugs, it produces synergistic weight-lowering effects. It is one of the innovative peptides that have attracted extensive attention in the current research of weight management and metabolic diseases.

The specific functions can be summarized as follows:
Appetite regulation: Acts on the satiety center to enhance satiety and reduce eating desire;
Weight management support: Demonstrates definite pharmacological activity in energy intake control and weight reduction;
Long-acting effect: Long half-life, low dosing frequency and favorable medication convenience;
Synergistic effect: Combined use with GLP-1 weight-loss drugs can further strengthen weight loss outcomes;
Metabolism-related research: Applied in drug development for metabolic diseases such as obesity and type 2 diabetes.

Main Application Fields
This product is an innovative peptide raw material for pharmaceuticals. Its applications are highly concentrated in pharmaceutical R&D and scientific research, making it a high-value research product.

The main application fields can be summarized as follows:
Innovative drug development: Used in preclinical and clinical research of new drugs related to obesity, chronic weight management and metabolic syndrome;
Research on compound weight-loss drugs: Serves as one of the key components of compound weight-loss formulations (combined with GLP-1 drugs);
Pharmaceutical research use: Supplied to universities, research institutes and pharmaceutical laboratories as a tool peptide for the study of appetite regulation mechanisms;
Peptide active pharmaceutical ingredient: Used for the supply of active pharmaceutical ingredients and intermediates of relevant innovative medicines;
Export trade and raw material supply: Provided as research peptide raw materials to pharmaceutical companies, research institutions and relevant traders, with specifications available upon customer requests.